MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, NEUP has $34,809,200 in assets. $5,385,256 in debts. $19,440,655 in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
1431.16%
Quick Ratio
1431.16%
Cash Ratio
1284.65%
Debt to Asset Ratio
15.47%
Unit: Dollar
Assets Breakdown
    • Cash and cash equivalents
    • Goodwill
    • Intangible assets, net
    • Prepaid expenses
Liabilities Breakdown
    • Aadditional paid-in capital, net...
    • Accumulated deficit
    • Accompanying warrants liability
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Restricted cash
---0
Cash and cash equivalents
19,440,655 22,170,414 13,649,638 14,210,745
Accounts receivable, non-trade
1,605,340 1,109,908 1,758 11,948
Restricted cash
-79,647 78,564 77,945
Prepaid expenses
611,913 26,954 222,319 740,193
Total current assets
21,657,908 23,386,923 13,952,279 15,040,831
Property and equipment, net
--2,573 2,771
Intangible assets, net
4,307,743 4,473,426 4,639,108 4,804,791
Operating lease right-of-use assets
--75,219 102,612
Goodwill
8,843,549 8,737,953 8,674,734 8,638,609
Total assets
34,809,200 36,598,302 27,343,913 28,589,614
Operating lease liability, net of current portion
---0
Other non-current liabilities
---0
Accounts payable
627,185 520,709 1,370,728 1,154,369
Accrued expenses and other current liabilities
886,124 2,065,599 3,668,338 2,950,077
Operating lease liability
--85,210 116,314
Total current liabilities
1,513,309 2,586,308 5,124,276 4,220,760
Contingent consideration
1,023,839 1,172,859 1,156,912 1,169,675
Deferred tax liability
390,733 425,527 460,320 495,113
Accompanying warrants liability
2,457,375 2,712,784 8,092,218 3,701,492
Total liabilities
5,385,256 6,897,478 14,833,726 9,587,040
Common stock, 0.00001 par value, 5,377,329 and 1,978,460 shares issued and outstanding at march 31, 2026 and june 30, 2025, respectively
54 54 23 19
Aadditional paid-in capital, net of subscription receivable
218,385,436 218,315,150 203,559,216 200,194,324
Accumulated other comprehensive loss, net of tax
-2,067,368 -2,225,265 -2,795,845 -2,845,066
Accumulated deficit
-186,894,178 -186,389,115 -188,253,207 -178,346,703
Total shareholders equity
29,423,944 29,700,824 12,510,187 19,002,574
Total liabilities and shareholders equity
34,809,200 36,598,302 27,343,913 28,589,614
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$19,440,655 Accounts receivable,non-trade$1,605,340 Prepaid expenses$611,913 Total current assets$21,657,908 Goodwill$8,843,549 Intangible assets, net$4,307,743 Total assets$34,809,200 Total liabilities andshareholders equity$34,809,200 Total shareholdersequity$29,423,944 Total liabilities$5,385,256 Accumulated deficit-$186,894,178 Accumulated othercomprehensive loss, net of tax-$2,067,368 Aadditional paid-incapital, net of...$218,385,436 Accompanying warrantsliability$2,457,375 Total currentliabilities$1,513,309 Contingent consideration$1,023,839 Deferred tax liability$390,733 Common stock, 0.00001par value,...$54 Accrued expenses andother current...$886,124 Accounts payable$627,185

Neuphoria Therapeutics Inc. (NEUP)

Neuphoria Therapeutics Inc. (NEUP)